| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―20 |
Clinical characteristics of newly diagnosed primary melanoma: a retrospective multicenter study before and four years after the COVID-19 pandemic onset |
E. Pennacchioli, L. Nespoli, D. Piazzalunga, V. Caliendo, P. Rossi, M. Clementi, et al. (+11) M. Mascherini, F. Cananzi, S. Asero, C. Caracò, P. Carcoforo, P. Del Fiore, C. Trevisol, F. Cavallin, A. Buja, P. Gallina, M. Rastrelli |
| 2 |
[GO] |
2025―Apr―03 |
Insights into Skin Cancer Prevention and Blood Donation During COVID-19 Pandemic: Acts of Solidarity and Voluntarism |
K. Grafanaki, F. Manti, S. Georgiou, C. Stathopoulos, A.J. Stratigos |
| 3 |
[GO] |
2025―Apr―03 |
Impact of the Covid-19 Pandemic on primary melanoma diagnoses within a single institution |
S. Gamage, J. Tharakan, S. Sheraz, S. Gupta, T. Carter |
| 4 |
[GO] |
2025―Apr―03 |
Evaluation of the impact of the COVID-19 pandemic on Melanoma diagnosis in Europe: A Meta-Analysis |
K. Seretis, N. Bounas, G. Gaitanis, I. Bassukas |
| 5 |
[GO] |
2024―Oct―23 |
Long lasting complete regression of a metastatic polyomavirus-positive Merkel Cell carcinoma after COVID-19 booster vaccination |
Ulrich Wesselmann, Hans M. Kvasnicka, Ahmet Bozkurt, Ulrike Wieland, Silke C. Hofmann |
| 6 |
[GO] |
2024―May―29 |
Role of the COVID-19 pandemic on the incidence and stage at initial diagnosis of cutaneous melanoma: a retrospective national study from the French Clinical Database of Melanoma Patients (RIC-Mel) |
F. Skowron, A. Seigneurin, S. Mouret, A. Khammari, J. Charles, M.-T. Leccia |
| 7 |
[GO] |
2024―May―29 |
Updates on CTCL diagnostic and therapeutic trends amidst the COVID-19 pandemic: insights from a referral center |
G. Roccuzzo, N. Macagno, C. Sarda, S. Ribero, P. Fava, P. Quaglino |
|
